Cancer Institute– A national cancer institute
designated cancer center

Alexander Colevas

Back to Profile

Publication Details

  • Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

    Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM, Haddad RI. N Engl J Med. 2007; 357 (17): 1705-15

    A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the head and neck compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and fluorouracil (PF), followed by chemoradiotherapy.

    PubMedID: 17960013

Stanford Medicine Resources:

Footer Links: